The most common pregabalin side effects are drowsiness, dizziness, blurred vision, dry mouth, weight gain and swollen hands or feet. Most are mild and settle within a few weeks as your body adjusts. Pregabalin long-term side effects can include continued weight gain, fluid retention, memory and concentration problems, and physical dependence, which is why pregabalin should never be stopped suddenly. Serious reactions — including allergic reactions, breathing difficulties, and thoughts of self-harm — are rare but need urgent medical attention.
Pregabalin is one of the most widely prescribed medicines in the UK, with millions of prescriptions dispensed every year for nerve pain, epilepsy and generalised anxiety disorder. It helps a great many people manage conditions that are otherwise difficult to treat. But like every effective medicine, it comes with side effects — some trivial, some that deserve close attention, and a few that have prompted regulatory warnings from the MHRA in recent years.
This guide walks through pregabalin side effects in detail: what's common, what's rare, what tends to happen in the first weeks versus what emerges with long-term use, who is most at risk, and — importantly — what you can actually do about each one. It is written for UK patients and aligns with NHS and MHRA guidance, but it is general information, not medical advice. Your prescriber knows your history; this article doesn't.0
Pregabalin (brand name Lyrica, among others) belongs to a class of medicines called gabapentinoids. It works by calming overactive nerve signalling in the brain and spinal cord. That mechanism is exactly why it helps with nerve pain, seizures and anxiety — and also exactly why its most common side effects are neurological: drowsiness, dizziness, slowed thinking and unsteadiness. The same "dampening" effect that quiets misfiring pain nerves also quiets systems you'd rather keep sharp, at least until your body adapts.
In the UK, pregabalin is prescribed for three main conditions:
Since April 2019, pregabalin has been a Class C controlled substance in the UK, reclassified because of its potential for misuse and dependence. That legal status doesn't make it a "bad" medicine — it means prescriptions are more tightly controlled and that dependence is a recognised, documented risk rather than a rare curiosity. We'll cover that properly in the long-term section, because it's one of the most important things patients aren't always told clearly.
According to the electronic Medicines Compendium (eMC) and NHS guidance, more than 1 in 10 people taking pregabalin experience at least one of the very common side effects. Most appear in the first one to two weeks, peak early, and fade as the body adjusts — typically within three to four weeks of a stable dose.
Drowsiness and sleepiness. The single most reported pregabalin side effect. You may feel heavily sedated in the first days, particularly with evening doses. For many patients this is actually welcome at night — pregabalin is often dosed with the larger portion in the evening for precisely this reason — but daytime grogginess can interfere with work and driving.
Dizziness. Light-headedness or a spinning sensation, usually worst when standing up quickly. Dizziness is the side effect most strongly linked to falls, which is why it matters so much in older adults.
Headache. Common in the early weeks and usually mild. Paracetamol is safe to take alongside pregabalin if needed.
|
Side effect |
What it feels like |
Usually settles? |
|---|---|---|
|
Blurred or double vision |
Difficulty focusing, especially reading |
Often, within weeks |
|
Dry mouth |
Persistent thirst, altered taste |
Often persists at some level |
|
Constipation |
Infrequent, hard stools |
Manageable; may persist |
|
Weight gain |
Increased appetite, gradual gain |
Tends to continue long term |
|
Swollen hands, ankles or feet |
Puffiness, tight shoes/rings |
May persist; report it |
|
Difficulty concentrating |
"Brain fog", word-finding trouble |
Improves for most, not all |
|
Memory problems |
Short-term forgetfulness |
Improves for most, not all |
|
Mood changes |
Elevated mood or irritability |
Variable — monitor closely |
|
Unsteadiness / poor coordination |
Clumsiness, stumbling |
Usually improves |
|
Increased appetite |
Cravings, especially carbohydrates |
Often persists |
|
Sexual difficulties |
Reduced libido, erectile difficulties |
Variable |
|
Nausea and vomiting |
Usually mild, early in treatment |
Usually settles |
Two of these deserve a closer look because they're the ones patients most often underestimate.
Weight gain affects a significant minority of pregabalin users and is driven by a genuine increase in appetite rather than fluid alone. In clinical trials, weight gain was dose-related — higher doses produced more gain — and it does not reliably plateau on its own. If your weight is climbing after the first month, raise it with your prescriber early rather than waiting for a review; dose adjustment and dietary planning work far better before ten kilograms than after.
Peripheral oedema (swollen ankles, feet and hands) is fluid retention, and while it's usually cosmetic and harmless, it is not something to ignore if you have heart problems. In people with heart failure, pregabalin-related fluid retention can worsen the underlying condition. New or worsening swelling plus breathlessness is a same-week GP appointment, not a "mention it next time" issue.
For most people, the sedation, dizziness and coordination problems are front-loaded: worst in week one, noticeably better by week two or three, and largely resolved within a month of reaching a stable dose. Every dose increase can briefly bring them back. Side effects with a metabolic or physical basis — weight gain, fluid retention, dry mouth — follow a different pattern and tend to persist for as long as you take the medicine, which is why they dominate the long-term picture below.
Serious reactions to pregabalin are uncommon, but they exist, and knowing the red flags matters more than memorising the full side effect leaflet. Split them into two tiers.
Thoughts of harming yourself or ending your life. - A small number of people taking pregabalin experience new or worsening suicidal thoughts, and the MHRA requires this warning on all gabapentinoids and antiepileptic medicines. If these thoughts arrive, tell someone the same day — your GP, NHS 111, or the Samaritans on 116 123. Do not stop the tablets abruptly on your own, because sudden withdrawal can make things worse; get medical guidance instead.
Hallucinations - seeing or hearing things that aren't there.
Marked confusion or disorientation that's new.
Muscle pain, tenderness or weakness combined with fever or dark urine - rare, but can signal muscle breakdown.
Yellowing of the skin or eyes possible liver involvement, rare.
New or rapidly worsening ankle swelling with breathlessness possible heart strain.
None of this is meant to alarm. The overwhelming majority of pregabalin patients never experience any of these. But serious side effects are precisely the ones where knowing in advance changes the outcome.
This is the section most guides skim, and it's the one that matters most if you've been taking pregabalin for months or years. Pregabalin long term side effects fall into five broad areas: weight and metabolic changes, fluid retention, cognitive effects, tolerance and dependence, and withdrawal on stopping. There is also an open research question about vision, and specific considerations for kidney function.
Unlike the sedation, which fades, pregabalin-related weight gain tends to accumulate. Long-term studies and post-marketing data show that a meaningful proportion of patients gain 5–10% of body weight or more over a year of treatment, driven mainly by appetite increase. For patients with diabetes — many of whom take pregabalin for diabetic nerve pain — this matters doubly, because weight gain can worsen glucose control and blood sugar may need closer monitoring.
Practical mitigation: weigh yourself fortnightly for the first three months, treat a 3–4 kg gain as the trigger for a conversation with your prescriber (not a crisis, a conversation), and build protein-forward meals early in treatment while appetite signals are shifting. Dose reduction, where clinically possible, is the most reliable fix.
Long-term pregabalin users commonly report ongoing puffiness of the ankles, feet and hands. In otherwise healthy people it's mostly a nuisance. In people with heart failure, kidney disease or on certain blood pressure medicines, chronic fluid retention can quietly load the cardiovascular system. Long-term users with heart conditions should have this reviewed at least annually, and any step-change in swelling investigated rather than attributed to the medicine by default.
Some long-term users describe persistent problems with short-term memory, word-finding and concentration. For most patients cognitive effects improve substantially after the first months, but a minority report that fog persists for the duration of treatment, and it is dose-related. Older adults are more susceptible, and in that group the combination of cognitive dulling, dizziness and unsteadiness raises real-world fall and fracture risk.
If cognition is affected long term, the options are the honest ones: dose review, slower titration, moving more of the dose to night-time, or discussing alternatives. What isn't sensible is quietly tolerating impairment that affects your work or safety without telling your prescriber it's happening.
This is the long-term effect behind pregabalin's 2019 reclassification as a Class C controlled drug in the UK, and it deserves plain language.
Tolerance means the same dose gradually produces less effect. Some long-term patients find their original dose controls pain or anxiety less well over time, creating pressure to escalate. Dose increases should only ever happen with your prescriber — self-escalation is how therapeutic use drifts into dependence.
Physical dependence means your nervous system adapts to the medicine's presence, so stopping suddenly produces withdrawal symptoms. Dependence is not the same thing as addiction — a patient taking pregabalin exactly as prescribed for two years is very likely physically dependent and doing nothing wrong. But it has a practical consequence: pregabalin must be tapered, never stopped abruptly.
Addiction risk compulsive use, craving, using more than prescribed — is elevated in people with a history of substance misuse, and prescribers are advised to weigh this before starting. If you notice yourself taking doses early, running out before the refill date, or thinking about the medicine between doses, that is a flag worth raising honestly with your GP. It is treatable, and UK GPs deal with it routinely and without judgement.
Stopping pregabalin abruptly after long-term use can cause insomnia, anxiety, headache, nausea, sweating, flu-like symptoms, irritability and — in people with epilepsy — rebound seizures. The NHS advises tapering over at least a week, and in practice long-term users at higher doses are often tapered over several weeks to months, stepping the dose down gradually under GP supervision.
The rule is simple: however long you've taken pregabalin, don't stop it yourself. Book the appointment, agree a taper schedule, and come off it in a controlled way.
Vision. Blurred vision usually settles early, but long-term users who notice persistent visual changes should have them checked — both to review the medicine and to rule out unrelated eye conditions. Routine opticians' appointments are worth keeping while on long-term treatment.
Kidney function. Pregabalin is cleared almost entirely by the kidneys. It doesn't damage healthy kidneys, but if kidney function declines with age or illness, the medicine accumulates and side effects intensify at a previously fine dose. Long-term users — especially over-65s and diabetics — should have kidney function checked periodically, and doses adjusted if it falls.
Mood. Long-term mood changes in either direction (flattening, low mood, or uncharacteristic elation) are worth reporting rather than normalising.
Knowing the typical sequence helps you distinguish "normal adjustment" from "something to report".
Days 1–7. Sedation, dizziness and unsteadiness peak. Brain fog is at its heaviest. Do not drive until you know how the medicine affects you; treat the first week as a no-driving week if at all possible. Taking the first doses in the evening softens the daytime impact.
Weeks 2–4. Neurological side effects ease noticeably for most people. Appetite changes often become apparent here — this is the window to establish eating habits before weight gain compounds. Dry mouth and constipation, if present, usually declare themselves by now.
Months 1–3. Sedation and dizziness should be minimal at a stable dose; if they're still limiting daily life, the dose or the medicine needs reviewing. Weight and ankle swelling become the things to actively monitor. Each dose increase temporarily resets the early side effects for a few days.
Months 3+. The long-term profile dominates: gradual weight change, persistent oedema in a minority, cognitive effects in a minority, and physical dependence as a background fact requiring a taper whenever treatment eventually ends. An annual medication review is the minimum sensible check-in for long-term users; six-monthly is better for over-65s.
Side effects are not evenly distributed. Five groups need extra caution:
Older adults (65+). Slower drug clearance, more co-medications, and greater vulnerability to dizziness make falls the headline risk. Lower starting doses and slower titration are standard practice. Families should watch for confusion being misattributed to age.
People with reduced kidney function. Because pregabalin is renally cleared, impaired kidneys mean higher blood levels from the same dose. Doses must be adjusted to kidney function — this is one of the most common reasons a previously well-tolerated dose "suddenly" causes problems.
People with respiratory conditions or on sedating medicines. The MHRA's respiratory depression warning applies particularly to those with COPD or sleep apnoea, and to anyone combining pregabalin with opioids, benzodiazepines, sleeping tablets or alcohol. These combinations multiply, rather than add, sedative load.
People with heart failure. Fluid retention can decompensate a struggling heart. Pregabalin isn't forbidden, but it needs monitoring and a low threshold for review.
People with a history of substance misuse. Higher risk of escalating use and dependence; prescribers usually monitor more closely and review more often. Honesty about history protects you here — it changes monitoring, not necessarily eligibility.
Pregnancy deserves its own mention: UK guidance advises that pregabalin may slightly increase the risk of birth defects if taken in the first trimester, and anyone who is pregnant or planning pregnancy should review the medicine with their doctor — again, without stopping it abruptly on their own.
Most side effect management comes down to a handful of unglamorous but effective habits:
1. Titrate slowly and change one thing at a time. Most side effects are dose-and-speed related. If a dose increase hits hard, your prescriber can slow the schedule.
2. Time your doses tactically. Weighting the dose toward evening turns sedation from a bug into a feature. Discuss the split with your prescriber or pharmacist.
3. Don't drink alcohol early in treatment. Alcohol amplifies every neurological side effect pregabalin has. Once stable, discuss whether modest amounts are reasonable for you.
4. Protect against falls in week one. Stand up slowly, use stair rails, keep floors clear — dull advice that prevents the most common pregabalin-related injury.
5. Weigh yourself and check your ankles. Fortnightly weigh-ins and an occasional look at sock lines catch the two stealthiest long-term effects early.
6.Hydrate and manage constipation early. Fluids, fibre and movement beat waiting until it's established. A pharmacist can recommend a suitable laxative if needed.
7. Keep a simple side effect diary for the first month. One line a day. It turns your medication review from vague impressions into usable information.
8. Never adjust or stop the dose yourself. Both directions — escalation and abrupt cessation — are where pregabalin problems concentrate.
9. Use your pharmacist. For interaction checks, timing questions and over-the-counter compatibility, a pharmacist is faster than a GP appointment and just as authoritative for those questions.
Paracetamol, ibuprofen and naproxen have no known interaction with pregabalin and are generally safe for everyday pain. The combinations that need medical supervision are the sedating ones: opioids (codeine, co-codamol, tramadol, morphine), benzodiazepines, sleeping tablets and alcohol — all of which stack with pregabalin's effect on breathing and alertness. Amitriptyline is sometimes deliberately co-prescribed for nerve pain but increases drowsiness. When in doubt, ask a pharmacist before combining anything, including herbal products.
Patients switching between the two gabapentinoids often ask whether the side effect profile changes. Broadly, no — the two medicines share the same mechanism and therefore the same core side effects: drowsiness, dizziness, weight gain, fluid retention, cognitive dulling and dependence risk. Both are Class C controlled drugs in the UK for the same reasons.
The practical differences are ones of degree and pattern. Pregabalin is absorbed more predictably and acts faster, which can mean side effects arrive more sharply after dose changes but also settle more predictably. Gabapentin's absorption is less linear, so its effects can feel more variable dose to dose. Weight gain and oedema are reported with both; neither has a clean advantage. Some patients simply tolerate one better than the other for reasons that aren't fully predictable in advance, which is why an intolerable side effect on one gabapentinoid doesn't automatically rule out the other — a supervised switch is a legitimate option to raise at a medication review.
What the comparison should *not* become is combination. The two medicines are not normally taken together, since stacking two drugs with identical mechanisms adds side effects without matching benefit; the rare exceptions are specialist-managed overlaps during a switch.
Drowsiness and dizziness are the two most common pregabalin side effects, affecting more than 1 in 10 people. Blurred vision, dry mouth, headache, weight gain, swollen ankles, constipation and difficulty concentrating are also common. Most neurological effects settle within a few weeks.
Most early side effects — sedation, dizziness, unsteadiness, brain fog — improve within two to four weeks as your body adjusts, and briefly return after dose increases. Weight gain, fluid retention and dry mouth are more likely to persist for as long as you take the medicine.
The main pregabalin long term side effects are ongoing weight gain, persistent fluid retention, memory and concentration problems in a minority of users, tolerance, and physical dependence — meaning the medicine must be tapered gradually rather than stopped suddenly to avoid withdrawal symptoms.
Pregabalin does not typically damage the kidneys or liver. However, it is cleared by the kidneys, so people with reduced kidney function need lower doses, and declining kidney function can intensify side effects at a previously well-tolerated dose. Liver reactions are rare.
Yes — weight gain is a recognised, dose-related pregabalin side effect driven mainly by increased appetite. It can't always be fully prevented, but early monitoring, dietary planning in the first month, and prompt dose review if weight climbs are the most effective countermeasures.
Pregabalin carries a recognised risk of dependence and misuse, which is why it became a Class C controlled drug in the UK in 2019. Taken as prescribed, most patients develop physical dependence (needing a taper to stop) without addiction. Risk of problematic use is higher in people with a history of substance misuse.
Stopping pregabalin abruptly can cause withdrawal symptoms including insomnia, anxiety, headache, nausea, sweating and flu-like illness — and rebound seizures in people with epilepsy. Always come off pregabalin with a gradual taper agreed with your GP, typically over at least a week and often longer after long-term use.
Seek emergency help for signs of allergic reaction (facial swelling, breathing difficulty), severe breathing suppression, or seizures. Contact your GP urgently for suicidal thoughts, hallucinations, marked confusion, or new swelling with breathlessness. Routine side effects that persist beyond a month deserve a medication review rather than silent tolerance.
Please log in to add a comment.
Comments........!